Colorectal Cancer Trial, Recruiting NCT04967183 Sponsor: Fundacin Biomedica Galicia Sur Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT04967183
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 50 and 65 years old.
  • People who have had at least one advanced polyp (a type of growth in the colon of a certain size or with specific cellular features) or at least three smaller polyps found and fully removed during a routine bowel cancer screening program.

Who may not be able to join:

  • People who have previously been diagnosed with bowel (colorectal) cancer.
  • People who had a large polyp (10mm or bigger) removed without a laboratory analysis being carried out on it to confirm what it was.
  • People who had more than 10 polyps found during their initial colonoscopy (a camera examination of the bowel).
  • People who have a condition called serrated polyposis syndrome (a condition involving a high number of certain types of bowel polyps).
  • People who have two or more close blood relatives (such as parents or siblings) who have had bowel cancer.
  • People who have an inherited condition that increases their risk of bowel cancer.
  • People who have a serious health condition that means their life expectancy is less than 5 years.
  • People whose initial colonoscopy did not fully examine the bowel lining.
  • People whose polyps were not completely removed during the initial procedure.
  • People who do not agree to participate after reading and considering the trial consent information.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0034988385824

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fundacin Biomedica Galicia Sur
Registry
ClinicalTrials.gov
Start date
1 June 2022
Est. completion
1 June 2025

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Rate of invasive CRC; Rate of interval CRC; Mortality; Rate of advanced colonic lesions; Frequency of participation in the surveillance strategy; Adverse effects

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov